Edith A. Perez, MD
About Edith A. Perez, MD
Edith A. Perez, MD, serves as the Chief Medical Officer at Bolt Biotherapeutics and is a Professor Emeritus at Mayo Clinic. She has extensive experience in oncology, having held leadership roles at Genentech and contributed to the launch of several cancer therapies.
Work at Bolt Biotherapeutics
Edith A. Perez serves as the Chief Medical Officer at Bolt Biotherapeutics, Inc., a position she has held since 2020. In this role, she oversees the company's medical affairs and contributes to the strategic direction of its oncology programs. Her extensive experience in the field of hematology and oncology informs her leadership at Bolt Biotherapeutics, where she focuses on innovative approaches to cancer treatment.
Education and Expertise
Edith A. Perez has a robust educational background in medicine and related fields. She earned her Doctor of Medicine (M.D.) from the University of Puerto Rico School of Medicine. She completed her residency in internal medicine at Loma Linda University Medical Center and pursued fellowship training in hematology and oncology at the University of California, Davis. Additionally, she has completed several executive programs, including the Executive Development Program at The Wharton School and the Harvard Executive Development Program.
Background
Edith A. Perez has a diverse professional background in oncology and medical affairs. Before joining Bolt Biotherapeutics, she worked at Genentech as Vice President and Head of the U.S. BioOncology Medical Unit, where she oversaw U.S. hematology and oncology medical affairs. She has also served as a Professor of Medicine at Mayo Clinic for 27 years, contributing to both clinical practice and education in the field of oncology.
Achievements
Throughout her career, Edith A. Perez has been involved in significant drug development initiatives. While at Genentech, she played a key role in the launch of six drugs, including Gazyva and Tecentriq. She is recognized for her strategic vision in clinical trial design and has led hundreds of trials. Additionally, she serves on the editorial boards of multiple academic journals and chairs the Health Equity Committee for Stand Up to Cancer, reflecting her commitment to advancing cancer care and research.
Professional Affiliations
Edith A. Perez is actively involved in various professional organizations. She is a member of the Board of Directors and the Clinical Advisory Board for Artiva Biotherapeutics. She has also served on the Board of Directors for the American Association for Cancer Research. Her involvement in these organizations highlights her commitment to advancing cancer research and promoting health equity within the field.